Frozen Embryo Transfers Carry Under-Publicized Cancer Risks, and the Fertility Industry Has No Incentive to Address Them
Source: Jordan Boyd. "Frozen Embryo Transfers Linked To Increased Childhood Cancer." October 30, 2026. thefederalist.com
The Gist
A big Danish study found children born from frozen embryos had roughly double the childhood cancer rate of naturally conceived children. The author argues this is one more under-reported risk of IVF and related technologies, and that the fertility industry makes too much money to police itself.
Conclusion
Assisted reproductive technology, especially frozen embryo transfer, carries real and under-acknowledged health risks to children and mothers, including higher childhood cancer rates, and the profit-driven fertility industry will not act on these risks without outside pressure.
Premises
- A large Danish registry study (over 1 million births, 1996-2012) found childhood cancer incidence of 23.6 per 100,000 person-years among ART-conceived children versus 18.3 among naturally conceived children.
- The rate was substantially higher for children born from frozen embryos (41.1 per 100,000), and also elevated after ICSI (27.9 per 100,000), while fresh-embryo IVF showed no specific cancer associations.
- The study's authors attribute the increase to the procedure rather than to underlying infertility.
- Most IVF transfers today use frozen embryos, yet these risks are not widely publicized and long-term data on current IVF methods will not exist until the 2040s, so today's IVF children are effectively the trial.
- IVF is also associated with other harms: preterm birth, low birth weight, congenital heart problems, neurodevelopmental disorders, birth defects, and maternal complications such as ovarian hyperstimulation and postpartum hemorrhage.
- The fertility industry is profitable and faces little legal or financial pressure to act on these risks, and has an incentive to downplay harms to avoid regulation and profit loss.
Assumptions
- The observed association in the Danish data reflects a causal effect of freezing/thawing (or ICSI) rather than confounding from differences in parents, clinical protocols, or embryo selection
- A relative increase in rate is the morally and practically relevant measure, even though absolute risks remain low
- Patients are not currently being adequately informed of these risks
- Industry profit motives are the main reason risks are underemphasized, rather than scientific uncertainty or normal research lag
- Greater disclosure or regulation is the appropriate response to the findings
- Findings from Danish births in 1996-2012 generalize to current IVF practice